New supplement trial aims to thinning hair in women over 45
NCT ID NCT07347145
First seen Jan 18, 2026 · Last updated May 12, 2026 · Updated 13 times
Summary
This study tests a daily supplement called Olistic Next Women in 60 women aged 45-65 who are starting to lose hair due to female pattern hair loss. For 6 months, some women will take the supplement and others a placebo, without knowing which they receive. The goal is to see if the supplement increases hair density and reduces shedding, while also checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY FEMALE PATTERN HAIR LOSS (FPHL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CentroDerm
RECRUITINGWuppertal, Barmen, 42287, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.